Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients
This study has been completed.
Sponsors and Collaborators: University of Alberta
Alberta Heritage Foundation for Medical Research
Royal Alexandra Hospital
Information provided by: University of Alberta
ClinicalTrials.gov Identifier: NCT00175175
  Purpose

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.


Condition Intervention
Osteoporosis
Hip Fracture
Behavioral: Allied health professional-run osteoporosis service ("case-management")

MedlinePlus related topics: Fractures Hip Injuries and Disorders Hip Replacement Osteoporosis
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Further study details as provided by University of Alberta:

Primary Outcome Measures:
  • The proportion of patients taking bisphosphonate therapy within 6 months of hip fracture

Secondary Outcome Measures:
  • Proportion of patients taking prescription osteoporosis treatment at 6 months and 12 months
  • Proportion in receipt of a BMD test at 6 months and 12 months
  • Proportion still adherent to osteoporosis treatments at 6 months and 12 months
  • Proportion of patients with recurrent fractures at 6 months and 12 months
  • Cost effectiveness analyses

Estimated Enrollment: 220
Study Start Date: March 2002
Detailed Description:

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

  Eligibility

Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hip fracture patient > 50 years of age
  • able to give consent (or proxy consent available)
  • lives within health region
  • no contraindications to bisphosphonate therapy

Exclusion Criteria:

  • refuses to participate or consent
  • dementia or delirium without a proxy consent available
  • nursing home or longterm care
  • pathologic fracture
  • chronic glucocorticoid use
  • already receiving prescription osteoporosis treatment (calcium and vitamin D do not preclude inclusion)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00175175

Locations
Canada, Alberta
University of Alberta Hospitals
Edmonton, Alberta, Canada, T6G 2B7
Sponsors and Collaborators
University of Alberta
Alberta Heritage Foundation for Medical Research
Royal Alexandra Hospital
Investigators
Principal Investigator: Sumit R Majumdar, MD, MPH University of Alberta
  More Information

Publications indexed to this study:
Study ID Numbers: AHFMR #200100791
Study First Received: September 9, 2005
Last Updated: September 13, 2006
ClinicalTrials.gov Identifier: NCT00175175  
Health Authority: Canada: Health Canada

Keywords provided by University of Alberta:
osteoporosis treatment
osteoporosis testing
hip fracture
quality improvement

Study placed in the following topic categories:
Hip Fractures
Femoral Fractures
Musculoskeletal Diseases
Fractures, Bone
Wounds and Injuries
Disorders of Environmental Origin
Osteoporosis
Bone Diseases, Metabolic
Leg Injuries
Bone Diseases

Additional relevant MeSH terms:
Hip Injuries

ClinicalTrials.gov processed this record on January 16, 2009